Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Syndrome and CYP3A7[original query] |
|---|
| Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism 2008 Jul 93 (7): 2909-12. Goodarzi Mark O, Xu Ning, Azziz Ricar |
| The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. American journal of obstetrics and gynecology 2012 May 206 (5): 447.e17-24. Haas David M, Lehmann Amalia S, Skaar Todd, Philips Santosh, McCormick Catherine L, Beagle Kyle, Hebbring Scott J, Dantzer Jessica, Li Lang, Jung Jees |
| A Genome-wide Association Study of Circulating Levels of Atorvastatin and Its Major Metabolites. Clinical pharmacology and therapeutics 2020 3 108 (2): 287-297. Turner Richard M, Fontana Vanessa, Zhang Jieying E, Carr Daniel, Yin Peng, FitzGerald Richard, Morris Andrew P, Pirmohamed Mun |
| Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome. European journal of clinical pharmacology 2021 Jan . Liu Hongxia, Xu Qinxia, Huang Wenyan, Zhao Qi, Jiang Zhihu, Kuang Xinyu, Li Zhiling, Sun Huajun, Qiu Xiaoy |
- Page last reviewed:Feb 1, 2024
- Content source: